Stock Events

Stock Events

Creo Medical Group 

$0.180800
53
+$0.00+0% Friday 12:55

Statistics

Day High
0.2
Day Low
0.2
52W High
0.2
52W Low
0.185
Volume
2,500
Avg. Volume
0
Mkt Cap
82.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30SepExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q1 2026
Next
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

63.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
11.9MRevenue
7.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMEOF. It's not an investment recommendation.
Legal & General Group
17
LGEN.LSE
Greencoat UK Wind
13
UKW.LSE
Standard Life
12
SDLF.LSE
Lloyds Banking Group
11
LLOY.LSE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap66.54B
Boston Scientific Corporation offers medical solutions that compete directly with Creo Medical's advanced energy devices, particularly in the field of minimally invasive surgeries.
Medtronic
MDT
Mkt Cap107.36B
Medtronic plc provides a wide range of medical technologies, including surgical devices that rival Creo Medical's offerings in energy-based surgical and therapeutic solutions.
Johnson & Johnson
JNJ
Mkt Cap618.61B
Johnson & Johnson, through its medical devices segment, competes in the same space as Creo Medical by offering a variety of surgical instruments and medical equipment.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, competing with Creo Medical's focus on minimally invasive surgical technologies.
Smith & Nephew
SNN
Mkt Cap12.94B
Smith & Nephew plc manufactures medical equipment for surgery, which competes with Creo Medical's surgical devices, especially in the areas of wound management and endoscopy.
Stryker
SYK
Mkt Cap126.42B
Stryker Corporation is a direct competitor in the medical technology field, offering surgical equipment and medical devices that challenge Creo Medical's product range.
Zimmer Biomet
ZBH
Mkt Cap17.67B
Zimmer Biomet Holdings, Inc. competes with Creo Medical in the development and marketing of surgical solutions and orthopedic devices.
Baxter International
BAX
Mkt Cap11.68B
Baxter International Inc. provides a broad range of medical devices that compete with Creo Medical's offerings, particularly in the areas of critical care and surgery.
Abbott Laboratories
ABT
Mkt Cap163.61B
Abbott Laboratories offers medical devices and healthcare solutions that compete across several of Creo Medical's key areas, including vascular therapy and minimally invasive surgeries.
Edwards Lifesciences
EW
Mkt Cap53.09B
Edwards Lifesciences Corporation is a competitor in the field of medical technology, focusing on products for surgical and critical care, which overlaps with Creo Medical's market.

About

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, the company provides injection needles, hemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, it offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.
Show more...
CEO
Mr. Craig Jonathan Gulliford
Country
United States
ISIN
GB00BZ1BLL44

Listings

STU
DE
1RC.STU
STU
DE
CREO.STU
LSE
GB
CREO.LSE
F
DE
1RC.F

0 Comments

Share your thoughts

FAQ

What is Creo Medical Group stock price today?▼
The current price of CMEOF is $0.18 USD — it has increased by +0% in the past 24 hours. Watch Creo Medical Group stock price performance more closely on the chart.
What is Creo Medical Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Creo Medical Group stocks are traded under the ticker CMEOF.
Is Creo Medical Group stock price growing?▼
CMEOF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Creo Medical Group has showed a +8.11% increase.
What is Creo Medical Group market cap?▼
Today Creo Medical Group has the market capitalization of 82.49M
When is the next Creo Medical Group earnings date?▼
Creo Medical Group is going to release the next earnings report on September 30, 2026.
What is Creo Medical Group revenue for the last year?▼
Creo Medical Group revenue for the last year amounts to 11.9M USD.
What is Creo Medical Group net income for the last year?▼
CMEOF net income for the last year is 7.61M USD.
In which sector is Creo Medical Group located?▼
Creo Medical Group operates in the Other sector.
When did Creo Medical Group complete a stock split?▼
Creo Medical Group has not had any recent stock splits.
Where is Creo Medical Group headquartered?▼
Creo Medical Group is headquartered in Chepstow, United States.